1. Guest, the 'News in Brief' for the week beginning 19th September 2022 is here.
    Dismiss Notice
  2. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Clinically accessible tools for documenting the impact of orthostatic intolerance on symptoms and function in ME/CFS, 2020, Jihyun et al

Discussion in 'ME/CFS research' started by Andy, Jun 23, 2020.

  1. Andy

    Andy Committee Member

    Hampshire, UK
    Paywall, https://content.iospress.com/articles/work/wor203169
    Sci hub, https://sci-hub.tw/10.3233/WOR-203169
  2. rvallee

    rvallee Senior Member (Voting Rights)

    However it ends up being called, dysautonomia is very prevalent in COVID-19 symptoms. Many people have experienced it for a short period, meaning there should be a window to be able to observe changes, essentially a reverse control where the recovered patient is their own control. Certainly one of the most disabling. So there should be a lot of attention in the near future.

    I really hope this makes it an acceptable respected thing. Even if ME in general remains a puzzle, this is clearly something that can be studied with objectivity and lead to some treatments.

    It may even all by itself force major changes to medicine, as this is almost always dismissed as anxiety. At least if it leads to some recognition that defaulting to anxiety has been disastrous in blocking access to effective treatments to millions for decades.
    MSEsperanza, Mithriel, ahimsa and 3 others like this.

Share This Page